Mercy Memorial Hospital Corporation

Mercy Memorial Hospital Corporation was paid $29.51M by Medicaid between Jan 2018 and Dec 2024, across 387 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.

33Billing provider infoMERCY MEMORIAL HOSPITAL CORPORATION
MONROE, MI 48162

33aNPI1811097223assigned 09/25/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$29.51M

24GClaims846,441

24DCodes billed387

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Michigan

Rank by total paid#39 of 86

Median peer was paid$21.55M

This provider vs. median1.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	124,996	$3.92M
2019	125,838	$3.87M
2020	103,391	$3.41M
2021	125,661	$4.65M
2022	111,211	$4.18M
2023	122,124	$4.68M
2024incomplete	133,220	$4.81M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	16%	26,194	24,025	$4.84M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	16%	37,971	35,396	$4.61M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	11%	12,660	11,668	$3.36M
G0378	Hospital observation service, per hour	6.9%	2,929	2,693	$2.04M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	5.3%	18,390	16,621	$1.56M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.6%	21,562	19,567	$1.07M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.8%	10,873	10,438	$837K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.7%	10,762	10,076	$796K
74177	Computed tomography, abdomen and pelvis; with contrast material	2.2%	5,074	4,931	$663K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.7%	6,455	5,377	$500K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.6%	5,182	4,643	$480K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.4%	17,180	5,071	$420K

375 more codes

70450	Computed tomography, head or brain; without contrast material	1.3%	4,761	$397K
90837	Psychotherapy session, about an hour	1.3%	5,461	$395K
96361	Intravenous infusion, hydration; each additional hour	1.3%	15,879	$377K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.2%	6,395	$365K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.2%	1,752	$356K
96375	Therapeutic injection; each additional sequential IV push	1.2%	14,020	$350K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	1.0%	7,623	$310K
71046	Radiologic examination, chest; 2 views	1.0%	8,734	$301K
71045	Radiologic examination, chest; single view	<1%	9,131	$290K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,811	$268K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	541	$214K
90834	Psychotherapy session, about 45 minutes	<1%	3,879	$197K
90791	Psychiatric diagnostic evaluation	<1%	1,953	$177K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	441	$154K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,139	$149K
99204	Doctor's office visit, new patient (more involved)	<1%	1,432	$144K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	4,815	$144K
80061	Lipid panel	<1%	10,197	$131K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,189	$126K
86900		<1%	4,339	$105K
84443	Thyroid stimulating hormone (TSH)	<1%	17,877	$104K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	2,862	$97K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,828	$90K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	6,294	$87K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,091	$84K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	22,960	$80K
80053	Comprehensive metabolic panel	<1%	32,586	$80K
97162		<1%	1,696	$80K
90792	Psychiatric diagnostic evaluation with medical services	<1%	657	$78K
99203	Doctor's office visit, new patient (routine)	<1%	1,174	$78K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	1,018	$76K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,960	$66K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	2,284	$63K
76830	Ultrasound, transvaginal	<1%	1,164	$62K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	679	$61K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	2,808	$60K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	52,039	$59K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	5,047	$59K
93975		<1%	548	$56K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,452	$51K
58558		<1%	61	$50K
90832	Psychotherapy session, about 30 minutes	<1%	1,427	$46K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	227	$46K
99232	Hospital visit by a doctor, follow-up day	<1%	1,240	$43K
72100		<1%	1,892	$42K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	77	$41K
84439		<1%	13,560	$40K
36415	Collection of venous blood by venipuncture	<1%	30,967	$39K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	229	$38K
72141		<1%	274	$37K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	327	$37K
76536		<1%	708	$37K
83036	Hemoglobin; glycosylated (A1C)	<1%	7,823	$36K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,729	$35K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,730	$35K
82607		<1%	4,827	$34K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	304	$34K
76801		<1%	620	$34K
59025	Fetal non-stress test	<1%	524	$33K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,489	$31K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	367	$30K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	13,954	$29K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	660	$28K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	7,493	$28K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,658	$28K
74018		<1%	2,220	$27K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,769	$25K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,834	$22K
10060		<1%	275	$22K
76642		<1%	641	$21K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	155	$19K
97166		<1%	515	$19K
80048	Basic metabolic panel (calcium, ionized)	<1%	19,313	$19K
82746		<1%	2,611	$18K
86780		<1%	2,548	$18K
96367		<1%	892	$18K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	275	$17K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,685	$16K
87428		<1%	452	$15K
81514		<1%	95	$15K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	59	$15K
73030		<1%	1,753	$14K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	217	$14K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	24	$14K
84481		<1%	1,589	$14K
97161		<1%	263	$13K
82947		<1%	2,323	$13K
73130		<1%	2,210	$13K
73630		<1%	2,434	$13K
85027		<1%	5,549	$12K
73610		<1%	2,207	$12K
70486		<1%	343	$11K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	144	$11K
90686		<1%	1,119	$11K
77066	Tomosynthesis, mammo	<1%	214	$11K
84702		<1%	3,967	$11K
86696		<1%	1,883	$11K
73562		<1%	2,075	$11K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	4,420	$11K
82728		<1%	1,797	$11K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	122	$10K
84403		<1%	749	$10K
93971		<1%	194	$10K
80074		<1%	448	$10K
83735		<1%	14,992	$10K
83550		<1%	2,318	$9K
93017		<1%	310	$9K
80076		<1%	6,942	$9K
72040		<1%	655	$8K
83540		<1%	2,606	$8K
99222	Initial hospital care, per day, moderate complexity	<1%	114	$8K
92523		<1%	62	$8K
73502		<1%	732	$8K
85610		<1%	9,825	$7K
86803		<1%	1,475	$7K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	26	$7K
86003		<1%	103	$7K
87086	Culture, bacterial; quantitative colony count, urine	<1%	6,531	$7K
83001		<1%	700	$7K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	619	$7K
73110		<1%	1,127	$7K
90715		<1%	1,586	$6K
76770		<1%	125	$6K
74021		<1%	125	$6K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	2,028	$6K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,270	$6K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	193	$6K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	68	$6K
93970		<1%	56	$6K
83525		<1%	873	$5K
72110		<1%	132	$5K
97165		<1%	102	$5K
72072		<1%	215	$5K
82670		<1%	339	$5K
87340		<1%	1,875	$5K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,747	$5K
84146		<1%	588	$5K
82570		<1%	2,086	$5K
99215	Doctor's office visit, returning patient (complex)	<1%	41	$5K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	119	$5K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	230	$5K
87522	Neg quan hep c or qual rna	<1%	248	$5K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	640	$5K
82043		<1%	1,563	$5K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	19	$4K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	265	$4K
0012A		<1%	122	$4K
86038		<1%	865	$4K
99238	Hospital discharge day management, 30 minutes or less	<1%	126	$4K
81025		<1%	14,187	$4K
97535	Self-care/home management training, each 15 minutes	<1%	407	$4K
86695		<1%	552	$4K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	139	$4K
83880		<1%	2,198	$4K
82784		<1%	449	$3K
86140		<1%	2,393	$3K
99239	Hospital discharge day management, more than 30 minutes	<1%	64	$3K
90677		<1%	167	$3K
81001		<1%	12,023	$3K
0011A		<1%	126	$3K
71271		<1%	53	$3K
82565		<1%	1,220	$3K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	530	$3K
85730		<1%	5,661	$2K
87631		<1%	1,666	$2K
84460		<1%	974	$2K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	28	$2K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	99	$2K
73564		<1%	64	$2K
83970		<1%	92	$2K
84484		<1%	12,646	$2K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	111	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	326	$2K
83655		<1%	289	$2K
90670		<1%	355	$2K
0001A		<1%	68	$2K
82550		<1%	1,973	$2K
81003		<1%	16,105	$2K
82105		<1%	224	$2K
84450		<1%	799	$2K
72050		<1%	39	$2K
97116		<1%	337	$2K
86762		<1%	1,049	$2K
86850		<1%	4,017	$2K
87581		<1%	277	$2K
87486		<1%	276	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	688	$2K
0064A		<1%	43	$2K
72131		<1%	52	$2K
83002		<1%	180	$2K
87077		<1%	1,529	$2K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	22	$1K
92526		<1%	32	$1K
90472	Immunization administration, each additional vaccine (list separately)	<1%	96	$1K
82950		<1%	549	$1K
71250		<1%	24	$1K
71101		<1%	171	$1K
83615		<1%	582	$1K
77065	Tomosynthesis, mammo	<1%	41	$1K
94726		<1%	28	$1K
74019		<1%	202	$1K
90651		<1%	25	$1K
0002A		<1%	33	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	97	$1K
85651		<1%	862	$1K
83690		<1%	9,490	$1K
99442		<1%	79	$1K
0004A		<1%	33	$1K
85652		<1%	1,104	$1K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	37	$1K
73080		<1%	307	$1K
94060		<1%	12	$1K
87186		<1%	932	$1K
36591		<1%	173	$1K
86376		<1%	118	$996.63
73590		<1%	284	$988.58
84144		<1%	79	$903.62
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	57	$900.24
80051		<1%	330	$798.77
82248		<1%	459	$788.22
83516		<1%	108	$781.23
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	12	$779.06
86706		<1%	146	$778.10
0134A		<1%	25	$754.47
82274		<1%	168	$725.44
85018		<1%	1,404	$697.95
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	274	$679.14
90656		<1%	70	$672.88
87150		<1%	40	$620.28
99308	Subsequent nursing facility care, per day, straightforward	<1%	13	$596.76
85379		<1%	3,108	$595.41
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	14	$590.04
86364		<1%	47	$572.32
0071A		<1%	15	$570.78
84153		<1%	54	$568.85
84550		<1%	324	$568.56
84520		<1%	363	$543.70
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	120	$534.58
0072A		<1%	14	$529.90
86901		<1%	4,340	$523.65
77080		<1%	14	$522.89
96158		<1%	17	$521.19
87070		<1%	351	$498.88
73090		<1%	163	$485.68
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	363	$475.91
0124A		<1%	15	$473.11
12001		<1%	512	$446.06
80305		<1%	43	$408.91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	363	$396.48
84156		<1%	250	$326.66
84100		<1%	444	$315.37
82785		<1%	39	$312.35
87040		<1%	1,961	$300.93
82533		<1%	38	$291.66
86431		<1%	129	$276.58
87184		<1%	328	$273.63
84132		<1%	378	$246.31
87503		<1%	55	$245.90
86708		<1%	41	$243.18
86704		<1%	43	$223.66
93000		<1%	25	$219.30
73140		<1%	48	$213.47
87480		<1%	134	$200.31
87088		<1%	208	$198.81
87510		<1%	134	$196.51
82977		<1%	72	$195.01
84145		<1%	45	$194.00
87660		<1%	134	$188.38
82150		<1%	440	$186.29
80069		<1%	28	$147.25
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	16	$138.72
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	879	$137.35
80164		<1%	26	$128.24
74022		<1%	197	$122.35
82310		<1%	38	$116.98
83605		<1%	3,296	$116.69
70498		<1%	13	$103.42
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,914	$103.28
99188		<1%	14	$96.73
84165		<1%	15	$89.40
87081		<1%	25	$88.16
90707		<1%	28	$81.01
87205		<1%	135	$75.97
86308		<1%	47	$68.25
72170		<1%	28	$57.04
83721		<1%	15	$56.08
82803		<1%	1,523	$54.21
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	5,220	$53.71
85014		<1%	113	$53.60
86225		<1%	14	$51.84
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	66	$50.36
96127		<1%	12	$43.52
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	16	$38.28
94664		<1%	1,690	$35.51
82040		<1%	13	$34.21
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	26	$32.67
87147		<1%	28	$32.54
86787		<1%	54	$31.09
90744		<1%	28	$28.23
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	140	$24.25
82140		<1%	27	$8.52
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	<1%	36	$8.51
85049		<1%	154	$6.81
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	1,303	$3.99
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	142	$2.78
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,381	$2.72
Q0247	Injection, sotrovimab, 500 mg	<1%	19	$1.45
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	16	$1.31
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	341	$1.31
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	26	$0.25
90723		0%	226	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	379	$0.00
J2250	Injection, midazolam hydrochloride, per 1 mg	0%	678	$0.00
82077		0%	2,579	$0.00
96376		0%	4,459	$0.00
91307		0%	28	$0.00
90680		0%	178	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	285	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	248	$0.00
J2060	Injection, lorazepam, 2 mg	0%	411	$0.00
91301		0%	274	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	51	$0.00
94761		0%	274	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	201	$0.00
J3010	Injection, fentanyl citrate, 0.1 mg	0%	894	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	761	$0.00
A9270	Non-covered item or service	0%	526	$0.00
J2704	Injection, propofol, 10 mg	0%	1,013	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	202	$0.00
J3490	Unclassified drugs	0%	257	$0.00
94760		0%	438	$0.00
90698		0%	79	$0.00
90716		0%	28	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	42	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	200	$0.00
12002		0%	12	$0.00
91306		0%	42	$0.00
70496		0%	12	$0.00
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	0%	30	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	78	$0.00
97802		0%	12	$0.00
J7999	Compounded drug, not otherwise classified	0%	14	$0.00
95886		0%	12	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	12	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	135	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	243	$0.00
80143		0%	1,678	$0.00
A9577	Injection, gadobenate dimeglumine (multihance), per ml	0%	303	$0.00
80179		0%	1,666	$0.00
90648		0%	339	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	80	$0.00
82010		0%	191	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	1,332	$0.00
12011		0%	26	$0.00
94729		0%	161	$0.00
J2405	Injection, ondansetron hydrochloride, per 1 mg	0%	1,867	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	27	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	78	$0.00
J1644	Injection, heparin sodium, per 1000 units	0%	346	$0.00
90633		0%	41	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	52	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	60	$0.00
99152		0%	160	$0.00
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	0%	12	$0.00
91312		0%	14	$0.00
91300		0%	145	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	13	$0.00
29125		0%	27	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	16	$0.00
90681		0%	25	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	15	$0.00
90461		0%	13	$0.00
90734		0%	24	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	41	$0.00
91313		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHARP, KVIN (VP REV CYCLE)